Peptides: The Next Drug Modality Stack
A new drug modality is emerging: AI is accelerating design, GLP-1 proves demand, and manufacturing is becoming the bottleneck.
Metabolic & obesity (GLP-1 proven)
Anchors
AI-driven design & discovery
Therapeutics platforms
Delivery & oral bioavailability
Discovery, screening & tools
Scale-up (the bottleneck)
